医療用フォーム硬化剤の世界市場見通し2023年-2029年

◆英語タイトル:Medical Foam Sclerosant Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23JU5189)◆商品コード:MMG23JU5189
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年6月(※2025年版があります。お問い合わせください。)
◆ページ数:79
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥468,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥608,400見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥702,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Medical Foam Sclerosant Market 調査レポートは次の情報を含め、グローバルにおけるの医療用フォーム硬化剤市場規模と予測を収録しています。・世界の医療用フォーム硬化剤市場:売上、2018年-2023年、2024年-2029年
・世界の医療用フォーム硬化剤市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医療用フォーム硬化剤市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ポリオキシエチレンラウリルエーテル成分」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

医療用フォーム硬化剤のグローバル主要企業は、Samarth Life Sciences Pvt Ltd、 Kreussler、 Merz Aesthetics、 Boston Scientific Corporation、 Roche Holding AG、 Siegfried Hameln GmbH、 Hameln Pharmaceuticals GmbH、 Lomapharm GmbH、 Shaanxi TIANYU Pharmaceutical Co., Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、医療用フォーム硬化剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の医療用フォーム硬化剤市場:タイプ別、2018年-2023年、2024年-2029年
世界の医療用フォーム硬化剤市場:タイプ別市場シェア、2022年
・ポリオキシエチレンラウリルエーテル成分、ポリドカノール成分、その他

世界の医療用フォーム硬化剤市場:用途別、2018年-2023年、2024年-2029年
世界の医療用フォーム硬化剤市場:用途別市場シェア、2022年
・病院、美容サロン、その他

世界の医療用フォーム硬化剤市場:地域・国別、2018年-2023年、2024年-2029年
世界の医療用フォーム硬化剤市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における医療用フォーム硬化剤のグローバル売上、2018年-2023年
・主要企業における医療用フォーム硬化剤のグローバル売上シェア、2022年
・主要企業における医療用フォーム硬化剤のグローバル販売量、2018年-2023年
・主要企業における医療用フォーム硬化剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Samarth Life Sciences Pvt Ltd、 Kreussler、 Merz Aesthetics、 Boston Scientific Corporation、 Roche Holding AG、 Siegfried Hameln GmbH、 Hameln Pharmaceuticals GmbH、 Lomapharm GmbH、 Shaanxi TIANYU Pharmaceutical Co., Ltd.

*************************************************************

・調査・分析レポートの概要
医療用フォーム硬化剤市場の定義
市場セグメント
世界の医療用フォーム硬化剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医療用フォーム硬化剤市場規模
世界の医療用フォーム硬化剤市場規模:2022年 VS 2029年
世界の医療用フォーム硬化剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医療用フォーム硬化剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医療用フォーム硬化剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:ポリオキシエチレンラウリルエーテル成分、ポリドカノール成分、その他
医療用フォーム硬化剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、美容サロン、その他
医療用フォーム硬化剤の用途別グローバル売上・予測

・地域別市場分析
地域別医療用フォーム硬化剤市場規模 2022年と2029年
地域別医療用フォーム硬化剤売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報(企業概要、事業概要、主要製品、売上、ニュースなど)
Samarth Life Sciences Pvt Ltd、 Kreussler、 Merz Aesthetics、 Boston Scientific Corporation、 Roche Holding AG、 Siegfried Hameln GmbH、 Hameln Pharmaceuticals GmbH、 Lomapharm GmbH、 Shaanxi TIANYU Pharmaceutical Co., Ltd.
...

This report aims to provide a comprehensive presentation of the global market for Medical Foam Sclerosant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Foam Sclerosant. This report contains market size and forecasts of Medical Foam Sclerosant in global, including the following market information:
Global Medical Foam Sclerosant Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Foam Sclerosant Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Medical Foam Sclerosant companies in 2022 (%)
The global Medical Foam Sclerosant market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Polyoxyethylene Lauryl Ether Component Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Medical Foam Sclerosant include Samarth Life Sciences Pvt Ltd, Kreussler, Merz Aesthetics, Boston Scientific Corporation, Roche Holding AG, Siegfried Hameln GmbH, Hameln Pharmaceuticals GmbH, Lomapharm GmbH and Shaanxi TIANYU Pharmaceutical Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Foam Sclerosant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Foam Sclerosant Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Foam Sclerosant Market Segment Percentages, by Type, 2022 (%)
Polyoxyethylene Lauryl Ether Component
Polydocanol Component
Others
Global Medical Foam Sclerosant Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Foam Sclerosant Market Segment Percentages, by Application, 2022 (%)
Hospital
Beauty Salon
Others
Global Medical Foam Sclerosant Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Foam Sclerosant Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Foam Sclerosant revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Foam Sclerosant revenues share in global market, 2022 (%)
Key companies Medical Foam Sclerosant sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Medical Foam Sclerosant sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Samarth Life Sciences Pvt Ltd
Kreussler
Merz Aesthetics
Boston Scientific Corporation
Roche Holding AG
Siegfried Hameln GmbH
Hameln Pharmaceuticals GmbH
Lomapharm GmbH
Shaanxi TIANYU Pharmaceutical Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Foam Sclerosant, market overview.
Chapter 2: Global Medical Foam Sclerosant market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Foam Sclerosant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Foam Sclerosant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Foam Sclerosant capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Medical Foam Sclerosant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Foam Sclerosant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Foam Sclerosant Overall Market Size
2.1 Global Medical Foam Sclerosant Market Size: 2022 VS 2029
2.2 Global Medical Foam Sclerosant Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical Foam Sclerosant Sales: 2018-2029
3 Company Landscape
3.1 Top Medical Foam Sclerosant Players in Global Market
3.2 Top Global Medical Foam Sclerosant Companies Ranked by Revenue
3.3 Global Medical Foam Sclerosant Revenue by Companies
3.4 Global Medical Foam Sclerosant Sales by Companies
3.5 Global Medical Foam Sclerosant Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical Foam Sclerosant Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical Foam Sclerosant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Foam Sclerosant Players in Global Market
3.8.1 List of Global Tier 1 Medical Foam Sclerosant Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Foam Sclerosant Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Foam Sclerosant Market Size Markets, 2022 & 2029
4.1.2 Polyoxyethylene Lauryl Ether Component
4.1.3 Polydocanol Component
4.1.4 Others
4.2 By Type – Global Medical Foam Sclerosant Revenue & Forecasts
4.2.1 By Type – Global Medical Foam Sclerosant Revenue, 2018-2023
4.2.2 By Type – Global Medical Foam Sclerosant Revenue, 2024-2029
4.2.3 By Type – Global Medical Foam Sclerosant Revenue Market Share, 2018-2029
4.3 By Type – Global Medical Foam Sclerosant Sales & Forecasts
4.3.1 By Type – Global Medical Foam Sclerosant Sales, 2018-2023
4.3.2 By Type – Global Medical Foam Sclerosant Sales, 2024-2029
4.3.3 By Type – Global Medical Foam Sclerosant Sales Market Share, 2018-2029
4.4 By Type – Global Medical Foam Sclerosant Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical Foam Sclerosant Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Beauty Salon
5.1.4 Others
5.2 By Application – Global Medical Foam Sclerosant Revenue & Forecasts
5.2.1 By Application – Global Medical Foam Sclerosant Revenue, 2018-2023
5.2.2 By Application – Global Medical Foam Sclerosant Revenue, 2024-2029
5.2.3 By Application – Global Medical Foam Sclerosant Revenue Market Share, 2018-2029
5.3 By Application – Global Medical Foam Sclerosant Sales & Forecasts
5.3.1 By Application – Global Medical Foam Sclerosant Sales, 2018-2023
5.3.2 By Application – Global Medical Foam Sclerosant Sales, 2024-2029
5.3.3 By Application – Global Medical Foam Sclerosant Sales Market Share, 2018-2029
5.4 By Application – Global Medical Foam Sclerosant Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medical Foam Sclerosant Market Size, 2022 & 2029
6.2 By Region – Global Medical Foam Sclerosant Revenue & Forecasts
6.2.1 By Region – Global Medical Foam Sclerosant Revenue, 2018-2023
6.2.2 By Region – Global Medical Foam Sclerosant Revenue, 2024-2029
6.2.3 By Region – Global Medical Foam Sclerosant Revenue Market Share, 2018-2029
6.3 By Region – Global Medical Foam Sclerosant Sales & Forecasts
6.3.1 By Region – Global Medical Foam Sclerosant Sales, 2018-2023
6.3.2 By Region – Global Medical Foam Sclerosant Sales, 2024-2029
6.3.3 By Region – Global Medical Foam Sclerosant Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medical Foam Sclerosant Revenue, 2018-2029
6.4.2 By Country – North America Medical Foam Sclerosant Sales, 2018-2029
6.4.3 US Medical Foam Sclerosant Market Size, 2018-2029
6.4.4 Canada Medical Foam Sclerosant Market Size, 2018-2029
6.4.5 Mexico Medical Foam Sclerosant Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medical Foam Sclerosant Revenue, 2018-2029
6.5.2 By Country – Europe Medical Foam Sclerosant Sales, 2018-2029
6.5.3 Germany Medical Foam Sclerosant Market Size, 2018-2029
6.5.4 France Medical Foam Sclerosant Market Size, 2018-2029
6.5.5 U.K. Medical Foam Sclerosant Market Size, 2018-2029
6.5.6 Italy Medical Foam Sclerosant Market Size, 2018-2029
6.5.7 Russia Medical Foam Sclerosant Market Size, 2018-2029
6.5.8 Nordic Countries Medical Foam Sclerosant Market Size, 2018-2029
6.5.9 Benelux Medical Foam Sclerosant Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medical Foam Sclerosant Revenue, 2018-2029
6.6.2 By Region – Asia Medical Foam Sclerosant Sales, 2018-2029
6.6.3 China Medical Foam Sclerosant Market Size, 2018-2029
6.6.4 Japan Medical Foam Sclerosant Market Size, 2018-2029
6.6.5 South Korea Medical Foam Sclerosant Market Size, 2018-2029
6.6.6 Southeast Asia Medical Foam Sclerosant Market Size, 2018-2029
6.6.7 India Medical Foam Sclerosant Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medical Foam Sclerosant Revenue, 2018-2029
6.7.2 By Country – South America Medical Foam Sclerosant Sales, 2018-2029
6.7.3 Brazil Medical Foam Sclerosant Market Size, 2018-2029
6.7.4 Argentina Medical Foam Sclerosant Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical Foam Sclerosant Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medical Foam Sclerosant Sales, 2018-2029
6.8.3 Turkey Medical Foam Sclerosant Market Size, 2018-2029
6.8.4 Israel Medical Foam Sclerosant Market Size, 2018-2029
6.8.5 Saudi Arabia Medical Foam Sclerosant Market Size, 2018-2029
6.8.6 UAE Medical Foam Sclerosant Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Samarth Life Sciences Pvt Ltd
7.1.1 Samarth Life Sciences Pvt Ltd Company Summary
7.1.2 Samarth Life Sciences Pvt Ltd Business Overview
7.1.3 Samarth Life Sciences Pvt Ltd Medical Foam Sclerosant Major Product Offerings
7.1.4 Samarth Life Sciences Pvt Ltd Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.1.5 Samarth Life Sciences Pvt Ltd Key News & Latest Developments
7.2 Kreussler
7.2.1 Kreussler Company Summary
7.2.2 Kreussler Business Overview
7.2.3 Kreussler Medical Foam Sclerosant Major Product Offerings
7.2.4 Kreussler Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.2.5 Kreussler Key News & Latest Developments
7.3 Merz Aesthetics
7.3.1 Merz Aesthetics Company Summary
7.3.2 Merz Aesthetics Business Overview
7.3.3 Merz Aesthetics Medical Foam Sclerosant Major Product Offerings
7.3.4 Merz Aesthetics Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.3.5 Merz Aesthetics Key News & Latest Developments
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Company Summary
7.4.2 Boston Scientific Corporation Business Overview
7.4.3 Boston Scientific Corporation Medical Foam Sclerosant Major Product Offerings
7.4.4 Boston Scientific Corporation Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.4.5 Boston Scientific Corporation Key News & Latest Developments
7.5 Roche Holding AG
7.5.1 Roche Holding AG Company Summary
7.5.2 Roche Holding AG Business Overview
7.5.3 Roche Holding AG Medical Foam Sclerosant Major Product Offerings
7.5.4 Roche Holding AG Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.5.5 Roche Holding AG Key News & Latest Developments
7.6 Siegfried Hameln GmbH
7.6.1 Siegfried Hameln GmbH Company Summary
7.6.2 Siegfried Hameln GmbH Business Overview
7.6.3 Siegfried Hameln GmbH Medical Foam Sclerosant Major Product Offerings
7.6.4 Siegfried Hameln GmbH Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.6.5 Siegfried Hameln GmbH Key News & Latest Developments
7.7 Hameln Pharmaceuticals GmbH
7.7.1 Hameln Pharmaceuticals GmbH Company Summary
7.7.2 Hameln Pharmaceuticals GmbH Business Overview
7.7.3 Hameln Pharmaceuticals GmbH Medical Foam Sclerosant Major Product Offerings
7.7.4 Hameln Pharmaceuticals GmbH Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.7.5 Hameln Pharmaceuticals GmbH Key News & Latest Developments
7.8 Lomapharm GmbH
7.8.1 Lomapharm GmbH Company Summary
7.8.2 Lomapharm GmbH Business Overview
7.8.3 Lomapharm GmbH Medical Foam Sclerosant Major Product Offerings
7.8.4 Lomapharm GmbH Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.8.5 Lomapharm GmbH Key News & Latest Developments
7.9 Shaanxi TIANYU Pharmaceutical Co., Ltd.
7.9.1 Shaanxi TIANYU Pharmaceutical Co., Ltd. Company Summary
7.9.2 Shaanxi TIANYU Pharmaceutical Co., Ltd. Business Overview
7.9.3 Shaanxi TIANYU Pharmaceutical Co., Ltd. Medical Foam Sclerosant Major Product Offerings
7.9.4 Shaanxi TIANYU Pharmaceutical Co., Ltd. Medical Foam Sclerosant Sales and Revenue in Global (2018-2023)
7.9.5 Shaanxi TIANYU Pharmaceutical Co., Ltd. Key News & Latest Developments
8 Global Medical Foam Sclerosant Production Capacity, Analysis
8.1 Global Medical Foam Sclerosant Production Capacity, 2018-2029
8.2 Medical Foam Sclerosant Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Foam Sclerosant Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Foam Sclerosant Supply Chain Analysis
10.1 Medical Foam Sclerosant Industry Value Chain
10.2 Medical Foam Sclerosant Upstream Market
10.3 Medical Foam Sclerosant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Foam Sclerosant Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Medical Foam Sclerosant in Global Market
Table 2. Top Medical Foam Sclerosant Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Medical Foam Sclerosant Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Medical Foam Sclerosant Revenue Share by Companies, 2018-2023
Table 5. Global Medical Foam Sclerosant Sales by Companies, (K Units), 2018-2023
Table 6. Global Medical Foam Sclerosant Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Medical Foam Sclerosant Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Medical Foam Sclerosant Product Type
Table 9. List of Global Tier 1 Medical Foam Sclerosant Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medical Foam Sclerosant Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Medical Foam Sclerosant Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Medical Foam Sclerosant Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Medical Foam Sclerosant Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Medical Foam Sclerosant Sales (K Units), 2018-2023
Table 15. By Type - Global Medical Foam Sclerosant Sales (K Units), 2024-2029
Table 16. By Application – Global Medical Foam Sclerosant Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Medical Foam Sclerosant Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Medical Foam Sclerosant Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Medical Foam Sclerosant Sales (K Units), 2018-2023
Table 20. By Application - Global Medical Foam Sclerosant Sales (K Units), 2024-2029
Table 21. By Region – Global Medical Foam Sclerosant Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Medical Foam Sclerosant Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Medical Foam Sclerosant Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Medical Foam Sclerosant Sales (K Units), 2018-2023
Table 25. By Region - Global Medical Foam Sclerosant Sales (K Units), 2024-2029
Table 26. By Country - North America Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Medical Foam Sclerosant Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Medical Foam Sclerosant Sales, (K Units), 2018-2023
Table 29. By Country - North America Medical Foam Sclerosant Sales, (K Units), 2024-2029
Table 30. By Country - Europe Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Medical Foam Sclerosant Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Medical Foam Sclerosant Sales, (K Units), 2018-2023
Table 33. By Country - Europe Medical Foam Sclerosant Sales, (K Units), 2024-2029
Table 34. By Region - Asia Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Medical Foam Sclerosant Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Medical Foam Sclerosant Sales, (K Units), 2018-2023
Table 37. By Region - Asia Medical Foam Sclerosant Sales, (K Units), 2024-2029
Table 38. By Country - South America Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Medical Foam Sclerosant Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Medical Foam Sclerosant Sales, (K Units), 2018-2023
Table 41. By Country - South America Medical Foam Sclerosant Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Medical Foam Sclerosant Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Medical Foam Sclerosant Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Medical Foam Sclerosant Sales, (K Units), 2024-2029
Table 46. Samarth Life Sciences Pvt Ltd Company Summary
Table 47. Samarth Life Sciences Pvt Ltd Medical Foam Sclerosant Product Offerings
Table 48. Samarth Life Sciences Pvt Ltd Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Samarth Life Sciences Pvt Ltd Key News & Latest Developments
Table 50. Kreussler Company Summary
Table 51. Kreussler Medical Foam Sclerosant Product Offerings
Table 52. Kreussler Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Kreussler Key News & Latest Developments
Table 54. Merz Aesthetics Company Summary
Table 55. Merz Aesthetics Medical Foam Sclerosant Product Offerings
Table 56. Merz Aesthetics Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Merz Aesthetics Key News & Latest Developments
Table 58. Boston Scientific Corporation Company Summary
Table 59. Boston Scientific Corporation Medical Foam Sclerosant Product Offerings
Table 60. Boston Scientific Corporation Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Boston Scientific Corporation Key News & Latest Developments
Table 62. Roche Holding AG Company Summary
Table 63. Roche Holding AG Medical Foam Sclerosant Product Offerings
Table 64. Roche Holding AG Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Roche Holding AG Key News & Latest Developments
Table 66. Siegfried Hameln GmbH Company Summary
Table 67. Siegfried Hameln GmbH Medical Foam Sclerosant Product Offerings
Table 68. Siegfried Hameln GmbH Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Siegfried Hameln GmbH Key News & Latest Developments
Table 70. Hameln Pharmaceuticals GmbH Company Summary
Table 71. Hameln Pharmaceuticals GmbH Medical Foam Sclerosant Product Offerings
Table 72. Hameln Pharmaceuticals GmbH Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Hameln Pharmaceuticals GmbH Key News & Latest Developments
Table 74. Lomapharm GmbH Company Summary
Table 75. Lomapharm GmbH Medical Foam Sclerosant Product Offerings
Table 76. Lomapharm GmbH Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Lomapharm GmbH Key News & Latest Developments
Table 78. Shaanxi TIANYU Pharmaceutical Co., Ltd. Company Summary
Table 79. Shaanxi TIANYU Pharmaceutical Co., Ltd. Medical Foam Sclerosant Product Offerings
Table 80. Shaanxi TIANYU Pharmaceutical Co., Ltd. Medical Foam Sclerosant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Shaanxi TIANYU Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 82. Medical Foam Sclerosant Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Medical Foam Sclerosant Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Medical Foam Sclerosant Production by Region, 2018-2023 (K Units)
Table 85. Global Medical Foam Sclerosant Production by Region, 2024-2029 (K Units)
Table 86. Medical Foam Sclerosant Market Opportunities & Trends in Global Market
Table 87. Medical Foam Sclerosant Market Drivers in Global Market
Table 88. Medical Foam Sclerosant Market Restraints in Global Market
Table 89. Medical Foam Sclerosant Raw Materials
Table 90. Medical Foam Sclerosant Raw Materials Suppliers in Global Market
Table 91. Typical Medical Foam Sclerosant Downstream
Table 92. Medical Foam Sclerosant Downstream Clients in Global Market
Table 93. Medical Foam Sclerosant Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medical Foam Sclerosant Segment by Type in 2022
Figure 2. Medical Foam Sclerosant Segment by Application in 2022
Figure 3. Global Medical Foam Sclerosant Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Medical Foam Sclerosant Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Medical Foam Sclerosant Revenue, 2018-2029 (US$, Mn)
Figure 7. Medical Foam Sclerosant Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Medical Foam Sclerosant Revenue in 2022
Figure 9. By Type - Global Medical Foam Sclerosant Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 11. By Type - Global Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 12. By Type - Global Medical Foam Sclerosant Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Medical Foam Sclerosant Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 15. By Application - Global Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 16. By Application - Global Medical Foam Sclerosant Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Medical Foam Sclerosant Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Medical Foam Sclerosant Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 20. By Region - Global Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 21. By Country - North America Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 22. By Country - North America Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 23. US Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 28. Germany Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 29. France Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 37. China Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 41. India Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 43. By Country - South America Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 44. Brazil Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Medical Foam Sclerosant Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Medical Foam Sclerosant Sales Market Share, 2018-2029
Figure 48. Turkey Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Medical Foam Sclerosant Revenue, (US$, Mn), 2018-2029
Figure 52. Global Medical Foam Sclerosant Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Medical Foam Sclerosant by Region, 2022 VS 2029
Figure 54. Medical Foam Sclerosant Industry Value Chain
Figure 55. Marketing Channels

※参考情報

医療用フォーム硬化剤(Medical Foam Sclerosant)は、医療分野において重要な役割を果たす薬剤の一種で、主に静脈瘤やその他の血管異常に関連する疾患の治療に利用されます。以下にその概念について詳しく説明します。

医療用フォーム硬化剤は、基本的には液体の薬剤に気体を加えて泡状にしたもので、血管内に注入されることによって特定の治療効果を発揮します。硬化剤は、血管を収縮させ、最終的には血管の閉塞を促進させることによって、血管の病変を治療するために使用されます。これにより、静脈の血流が正常化することが目指されています。

医療用フォーム硬化剤の特徴としては、第一にその効率性が挙げられます。従来の液体の硬化剤に比べ、泡状にすることによって、血管内での滞留時間が長くなり、効果的に治療を行うことが可能です。また、泡状のため、注入時の用量を制限でき、周囲の組織に与える影響を最小限に抑えることができます。これは特に、周囲の健康な組織を保護する観点から重要です。

次に、医療用フォーム硬化剤はその行動の速さと持続性においても優れています。注入後直ちに作用を発揮し、通常数か月にわたって効果が持続するため、患者にとって魅力的な選択肢となっています。そのため、静脈瘤の治療に従事する医師らにとって非常に価値のある治療法となっています。

医療用フォーム硬化剤の種類には、さまざまな成分が含まれています。最も一般的に使用されるのは、ポリドカノール(Polidocanol)や、リバックス(Sodium Tetradecyl Sulfate)などの化合物です。これらは、異なる濃度や配合比率で使用されることが多く、それによりさまざまな血管病変に対応した治療が行われます。さらに、これらの硬化剤には、より効果的な泡の生成を促すためのもう一つの成分、例えば空気や二酸化炭素に加えて、特定の合成ガスも使用されることがあります。

用途としては、医療用フォーム硬化剤は特に静脈瘤の治療に広く使われています。静脈瘤は、血液の逆流や血液の循環不良によって起こりますが、硬化剤を注入することにより、血管の内壁を刺激し、血管の収縮を促進します。これにより、静脈が占有していたスペースが再利用可能となり、正常な血流が保たれることが期待されます。また、医療用フォーム硬化剤は、他の血管病変、例えば動静脈奇形(AVM)や乏血症に対する治療にも利用されることがあります。

関連技術としては、医療用フォーム硬化剤を用いる治療法において、画像診断技術が重要です。エコー(超音波診断装置)やX線透視などを駆使して、治療中の血管の様子をリアルタイムで観察することができるため、より精密な治療が可能となります。これにより、医師は泡の分布や効果を確認しつつ、治療の効果を測ることができるのです。

また、最近では、3D画像技術の導入や、ナビゲーションシステムを活用した治療法が進んでおり、これにより複雑な血管パターンにおける治療精度が大幅に向上しています。これらの技術と医療用フォーム硬化剤の組み合わせにより、これまで治療が困難だった症例に対してもアプローチできる可能性が広がっています。

さらに、患者に対するアフターケアやフォローアップも重要な要素です。医療用フォーム硬化剤の治療後、患者には一定期間のコンプライアンスが求められます。適切な運動や生活習慣の見直しを行うことによって、再発を防ぐためのサポートが必要です。こうした点も、医療従事者がしっかりと指導することが求められます。

医療用フォーム硬化剤は、今後ますます進化し、適用範囲が拡大することが期待されます。新たな薬剤や治療法の開発は、患者にとっての選択肢を増やし、より安全で効果的な治療を提供するための努力が求められています。そのため、医療現場では研究や臨床データの蓄積、経験の共有が一層重要になってくるでしょう。

このように、医療用フォーム硬化剤は、静脈瘤やその他の血管異常に対する有効な治療手段として位置づけられており、その特性や技術により、今後も更なる発展が期待されています。将来的には、より多くの患者がこの治療法の恩恵を受けることができるようになるでしょう。医療用フォーム硬化剤に関する理解を深め、患者に最適な治療を提供することは、医療従事者にとって非常に重要です。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用フォーム硬化剤の世界市場見通し2023年-2029年(Medical Foam Sclerosant Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆